Urban metagenome
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA271013 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:This is the SIR model for disease spread of the Hong Kong flu in New York City in the late 1960's.
2022-01-27 | BIOMD0000001045 | BioModels
Project description:Here, we report genome sequences of the two bioluminescent S. aureus strains Xen31 and Xen36, obtained from PerkinElmer (#119242 and #119243, respectively). Xen31 was derived from the parental MRSA strain ATCC33591, a clinical strain isolated at Elmhurst Hospital in New York City. Xen36 was derived from parental strain ATCC 49525, a clinical isolate from a bacteremic patient. A copy of the modified luxABCDE operon from Photorhadbus luminescenst is integrated in the chromosome of Xen31 and in a native plasmid of Xen36.
2022-12-14 | E-MTAB-12210 | biostudies-arrayexpress
Project description:Bronx County, New York is the poorest urban county in the U.S.A., and residents are almost entirely Latino or African American. Cancer is the leading cause of premature death in the Bronx, with morality rates significantly higher than for New York City as a whole. Low-income/minority populations are more likely to be diagnosed with preventable and late-stage cancers than the general population, in part, due to lower screening rates. While research has addressed screening barriers in low-income/minority groups, depression, a common,potentially critical barrier, has received scant attention. Research suggests that depressed women are less likely to engage in cancer screening, especially mammography and Pap testing. The link between mental health and cancer screening is particularly important to address in the Bronx, which has the highest rates of self-reported serious psychological distress (a measure closely related to depression) in New York City. Depression affects almost 1 in 4 minority women, and while minorities often seek help for depression in primary care, primary care depression management often does not meet evidence-based standards. Drawing on the expertise and close collaboration of Bronx medical and social service providers and patient stakeholders, this study will determine whether a collaborative care intervention that addresses both depression and cancer screening needs simultaneously among women ages 50-64 is more effective at improving cancer screening and patient-reported outcomes for women with depression than an existing evidence-based cancer screening intervention alone.
To achieve this, the investigators will compare the effectiveness of these two interventions using a randomized controlled trial (RCT). In partnership with six Bronx Federally Qualified Health Centers (FQHCs), the investigators will recruit approximately 800 women ages 50-64 who screen positive for depression and are non-adherent with recommended cervical, breast, and/or colorectal cancer screenings. The investigators specific aims are to: 1) compare the impact of the two interventions on patient-reported outcomes, including cancer screening knowledge and attitudes, self-efficacy, depression-related stigma, provider referrals, participation in mental health care, medication adherence, quality of life, satisfaction with care and treatment decisions, and depression; 2) compare the effectiveness of the two interventions in increasing breast, cervical, and colorectal cancer screening; 3) determine whether reducing depression increases the likelihood that low-income women 50-64 will receive cancer screening; 4) determine whether effectiveness of the two interventions in increasing cancer screening varies according to patient characteristics, such as duration of depression, presence of other chronic conditions, and obesity.
This study is designed to increase the investigators understanding of how to enhance primary care systems’ ability to improve a range of outcomes related to cancer screening and depression among low-income minority women, and how to best support this population in making cancer-screening decisions.
| 2176921 | ecrin-mdr-crc
Project description:Microbial community patterns associated with Automated Teller Machine (ATM) keypads in New York City
| PRJNA330663 | ENA
Project description:ddRAD reads for New York City brown rats (Rattus norvegicus)
| PRJNA414893 | ENA
Project description:LMINDS: Environmental and other Legionella pneumophila subsp. pneumophila samples from New York City Water Distribution System
| PRJNA685824 | ENA
Project description:Study Design: The Cancer Alliance study was a collaboration of nine academic medical institutions in the New York city area and led by the New York Genome Center. Tumor-normal paired samples were submitted by the institutions for whole genome, whole exome and transcriptome sequencing and bioinformatics analysis at New York Genome Center. Relevant clinical histories were also collected. Raw sequence files were available to all collaborators. Variant call files were analyzed both manually by interpreters at NYGC and by IBM Watson Genome Analytics. This study was approved by a central institutional review board (IRB), Biomedical Research Alliance of New York, and by local IRBs, including Stony Brook University and Northwell Health. The study was supported in part by a grant from the IBM corporation (IBM Watson Health) to the New York Genome Center, New York Genome Center philanthropic funds and Rockefeller University grant # UL1TR000043 from the National Center for Advancing Translational Sciences (NCATS), and the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. The principal investigator Robert B. Darnell MD, PhD., is a Howard Hughes Medical Institute Investigator.
Results: Pending Publication of Analysis of Study
Conclusions: Pending Publication of Analysis of Study
| EGAS00001004013 | EGA
Project description:Metabarcoding New York City: 16S rRNA, 18S rRNA, and COI sequences of the Bronx River Estuary
| PRJNA606795 | ENA